Amit Akirov
Overview
Explore the profile of Amit Akirov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
670
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rudman Y, Fleseriu M, Masri-Iraqi H, Shochat T, Kushnir S, Shimon I, et al.
Eur J Endocrinol
. 2025 Feb;
192(3):266-276.
PMID: 39996332
Objective: Endogenous Cushing's syndrome (CS) has been linked with an increased risk of cancer. We aimed to evaluate the association between cancer risk and disease remission postsurgery in adrenal CS...
2.
Diker Cohen T, Rudman Y, Turjeman A, Akirov A, Steinmetz T, Calvarysky B, et al.
Diabetes Metab
. 2025 Feb;
51(3):101624.
PMID: 39961479
Aims: Glucagon-like peptide-1 receptor agonists (GLP1-RAs) show reno-protective effects in type 2 diabetes. Limited data is available on their use in post-transplant diabetes mellitus. We aimed to explore the effect...
3.
Diker Cohen T, Polansky A, Bergman I, Ayada G, Babich T, Akirov A, et al.
Diabetes Metab
. 2025 Feb;
51(3):101627.
PMID: 39956453
Aim: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are important anti-hyperglycemic medications with reno-protective benefits for patients with diabetic kidney disease. Their utilization in kidney transplant recipients (KTRs) remains underexplored due to...
4.
Akirov A, Rudman Y, Sharon Y, Shimon I, Kushnir S, Diker-Cohen T
J Neuroendocrinol
. 2025 Feb;
:e13494.
PMID: 39924868
Data on the risk of stroke in patients with hyperprolactinemia are limited. This study aimed to evaluate the association between hyperprolactinemia and ischemic stroke in a large cohort and identify...
5.
Masri-Iraqi H, Rudman Y, Shochat T, Kushnir S, Shimon I, Fleseriu M, et al.
J Endocrinol Invest
. 2025 Jan;
PMID: 39873891
Context: Leukocytosis frequently noted in Cushing's syndrome (CS), along with other blood cell changes caused by direct and indirect cortisol effects. Objective: Assess baseline white blood cell (WBC) profile in...
6.
Sharon Y, Shochat T, Rudman Y, Kushnir S, Zahavi A, Shimon I, et al.
Graefes Arch Clin Exp Ophthalmol
. 2025 Jan;
PMID: 39847049
Purpose: To investigate the risk of cataract in patients with Cushing's syndrome (CS) and evaluate whether disease onset occurs at an earlier age compared to general population. Methods: A nationwide...
7.
Rudman Y, Michaelis M, Shimon I, Dotan I, Shochat T, Kushnir S, et al.
Pituitary
. 2024 Dec;
28(1):10.
PMID: 39729122
Purpose: Patients with Cushing's syndrome (CS) have an increased venous thromboembolism (VTE) risk with most studies focusing on the perioperative period. The purpose of this study was to assess the...
8.
Sharon Y, Shochat T, Rudman Y, Kushnir S, Zahavi A, Shimon I, et al.
Acta Ophthalmol
. 2024 Nov;
PMID: 39498529
Purpose: Glaucoma incidence in patients with endogenous Cushing's syndrome (CS) has never been established. We aim to assess the risk for glaucoma among CS patients compared to controls and determine...
9.
Dery L, Shimon I, Rudman Y, Iraqi H, Kushnir S, Shochat T, et al.
J Endocrinol Invest
. 2024 Oct;
48(3):691-699.
PMID: 39476176
Purpose: Given prolactin's (PRL) multifaceted roles in mammary tissue, an association between hyperprolactinemia and breast cancer has been hypothesized. Despite previous studies not identifying this risk, we aimed to investigate...
10.
Rudman Y, Duskin-Bitan H, Masri-Iraqi H, Akirov A, Shimon I
Clin Endocrinol (Oxf)
. 2024 Aug;
101(6):648-658.
PMID: 39155611
Objective: The management of visual field damage in patients with macroprolactinomas is a major therapeutic challenge. We aimed to study the visual morbidity associated with macroprolactinoma and its outcomes following...